In 2020, Jennifer Doudna won the Nobel Prize in chemistry for her work on the CRISPR-Cas9 gene-editing technology that allows ...
The company seems to be doing everything it's supposed to be doing; the stock just isn't responding.
A preprint describing genetically edited human embryos is raising concerns among scientists that the U.S. is becoming more ...
Unlike earlier methods using CRISPR alone, this method works without introducing chromosomal abnormalities into the embryo or ...
Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...
Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct gene-editing experiments. The device, CRISPR-GPT, is an artificial intelligence lab ...
A new genetic technique allows for much more precise editing of human embryos than the CRISPR method used to date. A team of ...
It sounds like something straight out of a futuristic movie, but scientists may have just moved one step closer to making it ...
COMMENTARY: Why is this latest development generally being hailed as a scientific milestone rather than a giant ethical ...
Learn how CRISPR ETFs provide access to the gene-editing revolution, offering investors a diversified approach without picking individual biotech stocks.